ADENet: a novel network-based inference method for prediction of drug adverse events
- 18 January 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 23 (2)
- https://doi.org/10.1093/bib/bbab580
Abstract
Identification of adverse drug events (ADEs) is crucial to reduce human health risks and improve drug safety assessment. With an increasing number of biological and medical data, computational methods such as network-based methods were proposed for ADE prediction with high efficiency and low cost. However, previous network-based methods rely on the topological information of known drug-ADE networks, and hence cannot make predictions for novel compounds without any known ADE. In this study, we introduced chemical substructures to bridge the gap between the drug-ADE network and novel compounds, and developed a novel network-based method named ADENet, which can predict potential ADEs for not only drugs within the drug-ADE network, but also novel compounds outside the network. To show the performance of ADENet, we collected drug-ADE associations from a comprehensive database named MetaADEDB and constructed a series of network-based prediction models. These models obtained high area under the receiver operating characteristic curve values ranging from 0.871 to 0.947 in 10-fold cross-validation. The best model further showed high performance in external validation, which outperformed a previous network-based and a recent deep learning-based method. Using several approved drugs as case studies, we found that 32–54% of the predicted ADEs can be validated by the literature, indicating the practical value of ADENet. Moreover, ADENet is freely available at our web server named NetInfer (http://lmmd.ecust.edu.cn/netinfer). In summary, our method would provide a promising tool for ADE prediction and drug safety assessment in drug discovery and development.Funding Information
- National Key Research and Development Program of China (2016YFA 0502304, 2019YFA0904800)
- National Natural Science Foundation of China (81872800, 82173746, 82104066)
- Shanghai Municipal Education Commission
- Shanghai Post-doctoral Excellence Program (2018199)
- Shanghai Sailing Program (19YF1412700)
- China Postdoctoral Science Foundation (2019M661413)
- 111 Project (BP0719034)
This publication has 95 references indexed in Scilit:
- Pharmacodynamics, Safety, and Pharmacokinetics of BMS-663068, an Oral HIV-1 Attachment Inhibitor in HIV-1-Infected SubjectsThe Journal of Infectious Diseases, 2012
- Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based InferencePLoS Computational Biology, 2012
- Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progressionMolecular Medicine Reports, 2012
- Data-Driven Prediction of Drug Effects and InteractionsScience Translational Medicine, 2012
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- Development of CMX001 for the Treatment of Poxvirus InfectionsViruses, 2010
- Cytoscape 2.8: new features for data integration and network visualizationBioinformatics, 2010
- Solving the apparent diversity-accuracy dilemma of recommender systemsProceedings of the National Academy of Sciences of the United States of America, 2010
- Similarity-based virtual screening using 2D fingerprintsDrug Discovery Today, 2006
- The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and DiseaseScience, 2006